GGrantIndex
Sort

39,280 grants matching leukemia

PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)

$579,787
William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2006 · CA

Specific Adoptive Immunotherapy of Leukemia

$579,708
Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA

Socioeconomic determinants of childhood cancer outcomes in a large contemporary cohort

$579,707
Erin Marcotte · University Of Minnesota · R01 · FY2022 · CA

Selectively Targeting Oncogenic NRAS in Cancer

$579,512
Kevin M Shannon · University Of California, San Francisco · R01 · FY2015 · CA

Mechanisms of Intercellular Heme Homeostasis in Liver

$579,510
Makiko Yasuda · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK

Mechanisms and functions of N6-methyladenosine (m6A) in cancer

$579,461
Samie R Jaffrey · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA

Targeted therapy of B cell malignances with CAR-T cells of defined composition

$579,424
Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

A Proteogenomic Analysis of Platelets in Patients with Essential Thrombocythemia

$579,224
David J Kuter · Massachusetts General Hospital · R01 · FY2007 · HL

Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of “stem-like” CAR-T cells

$579,054
Shivani Srivastava · Fred Hutchinson Cancer Center · R37 · FY2023 · CA

Derivation of germline competent rabbit embryonic stem cell lines

$579,047
Jie Xu · Renova Life, Inc. · R44 · FY2010 · RR

Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer

$579,042
Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA

Illinois Oncology Research Association CCOP

$578,969
John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2007 · CA

Elucidation of Human Natural Killer Cell Development

$578,825
Aharon G Freud · Ohio State University · R01 · FY2023 · CA

Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies

$578,809
Sumithira Vasu · Ohio State University · R01 · FY2024 · CA

Organizing and Reorganizing Human Testis Development In Vitro

$578,704
Kyle E Orwig · Magee-Women'S Res Inst And Foundation · R01 · FY2023 · HD

Molecular Control of Plasmacytoid Dendritic Cell Development and Function

$578,680
Boris Reizis · New York University School Of Medicine · R37 · FY2020 · AI

Escape from CAR T surveillance through lineage plasticity

$578,670
Patricia A Ernst · University Of Colorado Denver · R01 · FY2022 · CA

Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity

$578,662
Juliane Gust · Seattle Children'S Hospital · R37 · FY2025 · CA

Alternative RNA splicing and protein products in leukemia outcome (PQ11)

$578,639
Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2014 · CA

Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds

$578,620
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2016 · CA

Unlocking the Potential of PI3K Inhibition in CLL

$578,547
Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Eukaryotic Ribosome Assembly

$578,517
Arlen W Johnson · University Of Texas At Austin · R35 · FY2018 · GM

Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines

$578,496
Stephen P Goff · Columbia University Health Sciences · R01 · FY2022 · CA

Single Cell Methods for Bioeffector Discovery and Analysis

$578,443
Brian O Bachmann · Vanderbilt University · R01 · FY2021 · CA

Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets

$578,421
Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI